Cell Lysis and Disruption Market Revenue 2024 to 2034
Cell Lysis and Disruption Market Revenue 2024 to 2034
The cell lysis and disruption market will expand from USD 5.7 Bn in 2024 to USD 13.49 Bn by 2034, at a 9% CAGR, fueled by rising biologics research, protein extraction needs, and advancements in cell-based therapeutics.
Report ID: 10597
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 5.70 Bn
Forecast Year,
USD 13.49 Bn
CAGR, 2025 -
9.00%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cell Lysis and Disruption Market Size Analysis
Cell Lysis and Disruption Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Reagents | 3.31 | 3.61 | 3.94 | 4.30 | 4.69 | 5.12 | 5.59 | 6.10 | 6.65 | 7.26 | 7.92 |
| Instruments | 2.39 | 2.61 | 2.83 | 3.08 | 3.36 | 3.65 | 3.97 | 4.32 | 4.71 | 5.12 | 5.57 |
Cell Lysis and Disruption Market Size By Technique 2024 to 2034 (USD )
| Technique | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mechanical | 1.94 | 2.11 | 2.30 | 2.51 | 2.74 | 2.99 | 3.26 | 3.55 | 3.87 | 4.22 | 4.61 |
| Chemical | 2.51 | 2.74 | 3.00 | 3.28 | 3.59 | 3.92 | 4.29 | 4.69 | 5.12 | 5.60 | 6.13 |
| Enzymatic/Others | 1.25 | 1.36 | 1.47 | 1.59 | 1.72 | 1.86 | 2.01 | 2.18 | 2.36 | 2.55 | 2.76 |
Cell Lysis and Disruption Market Size By Cell Type 2024 to 2034 (USD )
| Cell Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mammalian | 2.39 | 2.61 | 2.85 | 3.11 | 3.39 | 3.70 | 4.04 | 4.40 | 4.80 | 5.24 | 5.72 |
| Bacteria | 2.05 | 2.23 | 2.42 | 2.63 | 2.85 | 3.10 | 3.36 | 3.65 | 3.97 | 4.31 | 4.68 |
| Others | 1.25 | 1.37 | 1.50 | 1.65 | 1.80 | 1.97 | 2.16 | 2.36 | 2.59 | 2.83 | 3.10 |
Cell Lysis and Disruption Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Academic/Research | 2.17 | 2.36 | 2.58 | 2.81 | 3.06 | 3.34 | 3.64 | 3.97 | 4.33 | 4.72 | 5.15 |
| Biopharma | 2.39 | 2.61 | 2.85 | 3.11 | 3.39 | 3.70 | 4.03 | 4.40 | 4.80 | 5.24 | 5.71 |
| Diagnostics/Other | 1.14 | 1.24 | 1.35 | 1.47 | 1.59 | 1.73 | 1.88 | 2.05 | 2.23 | 2.42 | 2.63 |
Cell Lysis and Disruption Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.05 | 2.24 | 2.44 | 2.66 | 2.90 | 3.16 | 3.45 | 3.76 | 4.10 | 4.47 | 4.87 |
| Europe | 1.60 | 1.74 | 1.91 | 2.08 | 2.28 | 2.49 | 2.72 | 2.97 | 3.25 | 3.55 | 3.88 |
| Asia Pacific | 1.65 | 1.79 | 1.95 | 2.11 | 2.29 | 2.48 | 2.70 | 2.92 | 3.17 | 3.44 | 3.73 |
| Latin America | 0.23 | 0.26 | 0.29 | 0.33 | 0.37 | 0.41 | 0.46 | 0.52 | 0.58 | 0.65 | 0.73 |
| Middle East & Africa | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 | 0.23 | 0.24 | 0.25 | 0.26 | 0.28 | 0.29 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
